-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/opioid-chronic-pain-surveillance-report-2.pdf
April 01, 2022 - Canadian Pharmacists Journal 2020
Jan-Feb;153(1):52-8.
doi:10.1177/1715163519887766. … Assessing the
impact of clinical pharmacists on naloxone
coprescribing in the primary care setting.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-chronic-pain-review-jan-2020.pdf
January 01, 2020 - Journal
of the American Pharmacists Association:
JAPhA. 2020 Jan - Feb;60(1):225-34.e6. … Pharmacist. 2020;45(3):24-8.
Exclusion reason: Ineligible publication
type
112. Thomas J.
-
effectivehealthcare.ahrq.gov/products/blood-clots-hip-knee-surgery/research-protocol
August 06, 2010 - constituency of clinicians (surgeons, hematologists, hospitalists, internists, physician’s assistants, pharmacists
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
January 01, 2015 - including family practitioners, general internists, nurse practitioners, physician
assistants, nurses, pharmacists
-
effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
February 01, 2008 - constituency of
clinicians (surgeons, hematologists, hospitalists, internists, physician’s assistants,
pharmacists
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
February 01, 2008 - constituency of
clinicians (surgeons, hematologists, hospitalists, internists, physician’s assistants,
pharmacists
-
effectivehealthcare.ahrq.gov/sites/default/files/Disposition%20of%20Comments.pdf
September 03, 2019 - potential downside it presents as being a
“guideline” for antipsychotics is that busy providers,
pharmacists
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/Disposition%20of%20Comments.pdf
September 03, 2019 - potential downside it presents as being a
“guideline” for antipsychotics is that busy providers,
pharmacists
-
effectivehealthcare.ahrq.gov/products/palliative-care-integration/protocol
January 10, 2020 - educational materials;
Guidelines and position statements
Society of Pain and Palliative Care Pharmacists
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/delirium-disposition-comments.pdf
September 03, 2019 - potential downside it presents as being a
“guideline” for antipsychotics is that busy providers,
pharmacists
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
November 21, 2019 - and educational materials;
Guidelines and position statements
Society of Pain and Palliative Care Pharmacists
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_disposition-comments.pdf
May 27, 2014 - Pharmacists are
not clinicians but are considered providers. … of “clinician” is used; some consider
this to be any provider (e.g., nurse,
psychologist, doctor, pharmacist … section, we define home-visit
(i.e., a visit to the patient’s home by a provider,
usually a nurse or pharmacist
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
June 01, 2014 - available for consultation; case managers, physician extenders, occupational and
physical therapists, and pharmacists … patients of
the hospital’s geriatric ED “were prescribed five or more medications, and through the pharmacist
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_disposition-comments.pdf
May 29, 2013 - nonprofit medical society comprised of physicians,
nurses, nurse practitioners, physician assistants,
pharmacists
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-3.pdf
June 01, 2022 - Evaluation of a pharmacist-led naloxone
coprescribing program in primary care. … Patient acceptance of naloxone resulting
from targeted intervention from community
pharmacists to prevent … Assessing the
impact of clinical pharmacists on naloxone
coprescribing in the primary care setting.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/payer-usability_white-paper.pdf
February 01, 2014 - number of other users of evidence within their organizations who might offer useful input,
including pharmacists
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
July 01, 2013 - Key
Informants were patients, providers (allergists, a pediatric
pulmonologist, pharmacists, otorhinolaryngologists
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/opioid-chronic-pain-surveillance-report-3.pdf
June 01, 2022 - Evaluation of a pharmacist-led naloxone
coprescribing program in primary care. … Patient acceptance of naloxone resulting
from targeted intervention from community
pharmacists to prevent … Assessing the
impact of clinical pharmacists on naloxone
coprescribing in the primary care setting.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-map-hcbs-draft-technical-brief.pdf
December 07, 2023 - The collaborative models included
various healthcare professionals, including physicians, nurses, pharmacists … Impact of a pharmacist-physician
collaborative care model on patient
outcomes and health services utilization
-
effectivehealthcare.ahrq.gov/products/heart-failure-transition-care/research-protocol
June 10, 2013 - Does the effectiveness of interventions differ based on delivery personnel (e.g., nurse, pharmacist)?